The arrival of Retatrutide ZPHC, at a strength of 120mg, is generating considerable interest within the weight loss community. This novel dual GIP and GLP-1 receptor medication suggests to offer significant improvements in fat shedding compared to previous therapies. Initial clinical trials have shown marked declines in body mass , conceivably repr